CANCER GENE THERAPY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
CANCER GENE THERAPY
CANCER GENE THER
ISSN / eISSN
0929-1903 / 1476-5500
Aims and Scope
Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.
Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.
Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.
Subject Area
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
GENETICS & HEREDITY
MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
9.30
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology - Molecular Biology | Q1 | #86/380 |
| Biochemistry, Genetics and Molecular Biology - Molecular Medicine | Q1 | #39/171 |
| Biochemistry, Genetics and Molecular Biology - Cancer Research | Q1 | #51/214 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| BIOTECHNOLOGY & APPLIED MICROBIOLOGY - SCIE | Q1 |
| GENETICS & HEREDITY - SCIE | Q1 |
| MEDICINE, RESEARCH & EXPERIMENTAL - SCIE | Q1 |
| ONCOLOGY - SCIE | Q1 |
H-index
80
Country/Area of Publication
ENGLAND
Publisher
Springer Nature
Publication Frequency
Monthly
Year Publication Started
1999
Annual Article Volume
145
Open Access
NO
Contact
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started